Location
United States, North America
Cheque size
$100K - $5M
Investment Stage
Seed
Series A
Series B
Focus Areas
Health IT
Health & Hospital Services
Digital Health
BioTech
Pharmaceuticals
Medical Devices
About Investor
David Migl works as a Senior Associate at RA Capital, focusing on Medical Devices, Pharmaceuticals, BioTech, Health & Hospital Services, Health IT, Diagnostics, and Digital Health at seed, Series A, and Series B stages with investment ranges from $100K to $5.0M. He is an Analyst on the Investment Team at RA Capital Management, holds a PhD from Harvard University, and specializes in conducting due diligence on biotechnology companies.
Similar Investors
AL
Abdul Ly
United States, North America
$1M - $4M
Seed
,Series A
,PS
Paul Straub
United States, North America
$100K - $2M
Pre Seed
,Seed
,SA
Shaun Abrahamson
United States, North America
$250K - $1M
Pre Seed
,Seed
,RF
Riley Florsheim
United States, North America
$100K - $5M
Pre Seed
,Seed
,SB
Steve Brownlie
United States, North America
$250K - $1.4M
Pre Seed
,Seed
,DG
Danielle Graham
Canada, North America
$100K - $300K
Pre Seed
,Seed
,Is this Your Profile?
If you have any updates, please fill out our form.